
Super excited to share our exciting new work with you. sciencedirect.com/science/ar… Great collaborative effort! @carmenbergom @DrLPedersen @carlavripoll @muallaozcan @RentschlerLab @WUSTLmed @DoctorPhillEP @WUSTLnews @WashUCardiology

Heart failure Transplant cardiologist, basic/translational researcher.

Super excited to share our exciting new work with you. sciencedirect.com/science/ar… Great collaborative effort! @carmenbergom @DrLPedersen @carlavripoll @muallaozcan @RentschlerLab @WUSTLmed @DoctorPhillEP @WUSTLnews @WashUCardiology

In 100% agreement Exercise should be a prescribed New @JACCJournals @ACCinTouch scientific statement jacc.org/doi/10.1016/j.jacc.…

Apte Receives 2026 APVRS International Award Lecture | Ophthalmology & Visual Sciences ophthalmology.wustl.edu/apte…

New work from our lab led by @AbeBayer identifies PIGR and CPVL as immune-related biomarkers of anthracycline cardiotoxicity: ahajournals.org/doi/10.1161/… @BidmcCvi @TuftsMedSchool
Very excited to share our new paper using plasma proteomics to look for potential biomarkers in anthracycline toxicity now out in @CircHF! We find new immune proteins that correlate with decreased LVEF in lymphoma/leukemia patients after anthracycline tx ahajournals.org/doi/10.1161/…

📢 New Review Cardiovascular aging through the lens of Blue Zones What can the world's longest-lived populations teach us about cardiovascular aging? Corresponding author: Dr. Ali Javaheri @Alicardsdoc 🔗 oaepublish.com/articles/jca.… #CardiovascularAging #BlueZones #Longevity

We identified RACGAP1 as a novel biomarker for atrial fibrillation in heart failure, validated across two large independent patient cohorts @JulioChirinosMd @DLMANN_MD @MorenoMDPhD @Alicardsdoc #Epeeps ahajrnls.org/3Rgb4fX

Longevity research is being starved of funds just when the US needs to be more competitive. Have assembled a team working on it. Launch date: April 2026 nytimes.com/2026/03/13/us/hi…

Increased dephospho-uncarboxylated matrix Gla-protein levels were associated with adverse outcomes in heart failure @DLMANN_MD @Alicardsdoc @mkvidula @mariejoedib @JulioChirinosMd @PennCardiology ahajrnls.org/4a2AnHL

📣🎉 Exciting news! Our lab’s new paper in #CirculationHeartFailure reports a gene therapy for arrhythmogenic cardiomyopathy. Restoring connexin-43 improves electrical & mechanical coupling, rescues disease & extends survival across severe ACM genotypes. ahajournals.org/doi/10.1161/…

Thrilled to share our new preclinical paper: low-dose (nonablative) cardiac radiation reduces VT/VF in NICM — associated with improved ventricular conduction and sympathetic nerve distribution. Grateful for our stellar team: @alicardsdoc @carmenbergom @drlpedersen @doctorphillep @rentschlerlab and first author Devaki Abhyankar. 🔗 doi.org/10.1016/j.jacep.2025… #Electrophysiology #VT #CardioOncology #TranslationalScience @uclahealthnews @jaccjournals

Congratulations @LodhiLab @RazaniLab @BrestoffLab this is awesome !
Happy to share our new paper in @Nature led by staff scientist Xuejing Liu @Jessielxj2. We report identification of a UCP1-independent pathway of brown fat thermogenesis involving ATP-consuming metabolism of BCFA in peroxisomes. #Obesity #T2D nature.com/articles/s41586-0… @WashUDeptMed

Single-nucleus RNA-seq reveals CD47 as a key driver of doxorubicin cardiomyopathy. Blocking CD47 protects the heart—offering a new therapeutic path. 🫀🧬@SDPrabhuMD @AartiAsnaniMD @BKopeckyMDPhD @twinsmc18 @AhmedAADiab @carmenbergom @Alicardsdoc ahajournals.org/doi/full/10.…

Blocking #CD47 has emerged as promising therapy in #CVD. Check out work in @CircAHA by Zhen Guo of @Alicardsdoc lab identifying CD47 in #cardiomyopathy #heartfailure induced by doxorubicin & targeting it as novel therapy. Great partnering with you on this. ahajournals.org/doi/10.1161/…

🚨Two new JACC Advances papers drop today linking SGLT2 inhibitors ↔ apolipoprotein M (ApoM) across very different settings—ambulatory HFrEF (DEFINE-HF) and acute inflammation (LPS-sepsis & COVID-19). Let’s unpack why this kidney-liver-vascular axis matters. A 🧵 1️⃣/15

medicine.washu.edu/news/stra… Great collaborative effort with @ApteLab @washumedicine @WashUCardiology @ZSky17 identifying a new role for ApoM in macular degeneration

Stereotactic arrhythmia radiotherapy (STAR) treats VT by locally increasing ERP, not increasing scar burden #AHAJournals #Epeeps @pmjboyle @Alicardsdoc @SBRTCR @brianzenger @carmenbergom @JulieSchwarz14 @RentschlerLab doi.org/10.1161/CIRCEP.124.0…